Company Number: 14528308

Analysis Date: 2025-07-29 12:57 UTC

1. Risk Rating: HIGH

Justification: SOMMERS-GOSLING LTD is a very recently incorporated private limited company classified as dormant, with minimal financial activity and negligible net assets (£100). The absence of trading history, combined with the dormant status and minimal cash, presents high risk from a financial stability and operational sustainability perspective.

2. Key Concerns:

• Dormant Status & Lack of Trading Activity: The company has filed dormant accounts indicating no significant business operations or income, which raises concerns about its current revenue generation and sustainability.
• Minimal Financial Resources: With net assets and cash at only £100, the company has almost no financial buffer to meet liabilities or invest in operations.
• Single Director and Shareholder Control: The company is wholly controlled by one individual who is both sole director and 100% shareholder, concentrating decision-making power and limiting governance oversight.

3. Positive Indicators:

• Up-to-date Filings and Compliance: The company has no overdue accounts or confirmation statement filings, demonstrating compliance with statutory requirements.
• Clear Ownership and Management: Ownership and control are transparent, with full disclosure of the sole director and person with significant control.
• Focused Industry Classification: The company is registered under real estate activities, a sector that can be capital intensive but potentially lucrative if operations commence.

4. Due Diligence Notes:

• Investigate the company’s business plan and intended timeline to move from dormant to active trading status.
• Review background and financial capacity of the sole director/shareholder to support future capital requirements.
• Confirm any related party or connected company activities that might impact financial viability or risk exposure.
• Monitor subsequent filings and operational announcements for indications of business commencement or capital injections.